Effect of AIV007 by Periocular Administration in Subjects with Macular Edema Secondary to Neovascular Age-related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME)

NCT05698329 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Neovascular Age-related Macular Degeneration
Diabetic Macular Edema
Macular Edema

Interventions

DRUG: AIV007

Sponsor

AiViva BioPharma, Inc.